Cite
APA Citation
Sabrina, P., Magenta, A., D'Agostino, M., Martino, F., Barillà, F., Satta, N., Frias, M., Gencer, B., Mach, F., & Vuilleumier, N. (2018). anti-apolipoprotein A1 (APOA1) autoantibodies disrupt the cholesterol pathway via SREBP-2 and decrease circulating MIR-33A in hypercholesterolaemic children. Atherosclerosis, 275, e42–e43. http://access.bl.uk/ark:/81055/vdc_100066561972.0x00005a